7 Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLC. (January 2016) - MacDonagh, L.; Gray, S.G.; Cuffe, S.; Finn, S.P.; O'Byrne, K.J.; Barr, M.P.